GlassScriptPhysician profile
Vikas Kalra
NPI 1023270550
$16,787.06
in general payments reported to CMS, 2019-2025
41 companies · $2,307 in 2025
The $2,307 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,216 · 2020: $2,392 · 2021: $2,343 · 2022: $1,466 · 2023: $2,626 · 2024: $2,438 · 2025: $2,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,875 · Travel and Lodging: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,875.17 |
| Travel and Lodging | $495.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,344.15 | 2019-2021 | |
| Medtronic, INC. | $2,087.75 | 2021-2025 | Azure Xt Dr Mri Surescan, Symplicity G3, Mycarelink |
| Biosense Webster, INC. | $847.94 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $839.24 | 2021-2025 | Aveir, Assurity, Amplatzer Amulet |
| Boston Scientific Corporation | $673.52 | 2019-2025 | Watchman, Watchman Access System, Resonate El Icd Vr |
| Pfizer INC. | $616.20 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $588.32 | 2022-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $506.86 | 2022-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.49 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $340.63 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $220.69 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $184.74 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $184.20 | 2025 | Amvuttra, Onpattro |
| Actelion Pharmaceuticals US, INC. | $175.14 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $167.43 | 2023-2025 | Repatha |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $156.65 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals LP | $138.68 | 2022-2024 | Farxiga, Wainua |
| Kiniksa Pharmaceuticals International, Plc | $118.20 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $108.36 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $93.55 | 2023-2024 | Verquvo |
| Baxter Healthcare | $90.47 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $83.21 | 2023 | Arcalyst |
| Atricure, INC. | $82.39 | 2022-2023 | |
| Amarin Pharma, INC. | $72.62 | 2019-2023 | |
| Scpharmaceuticals INC. | $71.14 | 2024-2025 | |
| Esperion Therapeutics, INC. | $69.24 | 2023-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $63.24 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $55.33 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $44.31 | 2022-2023 | |
| Terumo Medical Corporation | $44.08 | 2024 | Tr Band, Glidesheath Slender, Metacross Otw |
| Biotronik INC. | $38.06 | 2020-2023 | Acticor 7 Vr-T Dx |
| Heartflow, INC. | $35.36 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.79 | 2019-2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $29.02 | 2023-2024 | |
| Vifor Pharma, INC. | $27.96 | 2021 | |
| Mallinckrodt Hospital Products INC. | $21.73 | 2024 | Acthar |
| Nuwellis, INC. | $20.90 | 2023 | Aquadex Smartflow Console |
| Ultragenyx Pharmaceutical INC. | $17.15 | 2019 | |
| Vital Connect, INC | $16.02 | 2023 | Vitalpatch Rtm |
| Chiesi USA, INC. | $15.84 | 2023 | Cleviprex, Kengreal |
| Gilead Sciences, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Kalra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.